Otsuka (OTCMKTS:OTSKY) Shares Gap Up – Here’s Why

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) gapped up before the market opened on Friday. The stock had previously closed at $36.05, but opened at $38.50. Otsuka shares last traded at $38.50, with a volume of 20,308 shares traded.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Otsuka from a “hold” rating to a “strong-buy” rating in a report on Friday, October 9th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Otsuka currently has a consensus rating of “Moderate Buy”.

Otsuka Price Performance

The stock has a market cap of $41.47 billion, a price-to-earnings ratio of 15.50, a price-to-earnings-growth ratio of 2.59 and a beta of 0.09. The company has a current ratio of 2.21, a quick ratio of 1.65 and a debt-to-equity ratio of 0.05. The stock has a fifty day simple moving average of $37.32 and a 200-day simple moving average of $35.57.

Otsuka (OTCMKTS:OTSKY) last posted its quarterly earnings data on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The company had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. As a group, equities research analysts expect that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 EPS for the current year.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare company that oversees the Otsuka Group’s pharmaceutical, nutraceutical and consumer health businesses. The company’s operations are primarily conducted through subsidiaries, including Otsuka Pharmaceutical Co, Ltd., which researches, develops, manufactures and markets prescription medicines, over-the-counter products and health-related foods.

Otsuka’s pharmaceutical activities focus on areas such as psychiatry, oncology, cardiovascular and renal medicine, and several other specialized therapeutic fields.